The FDA approved another topoisomerase 1 inhibitor for the treatment of metastatic colorectal cancer
In 1996, the U.S. Food and Drug Administration (FDA) approved another topoisomerase 1 inhibitor – irinotecan (Camptosar) – for the treatment of metastatic colorectal cancer.
Tags:
Source: U.S. National Library of Medicine
Credit:
